The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.
Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.
We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.
The latest cancer waiting times show an 8% drop in the number of people starting cancer treatment in January, compared with figures from January 2020.
A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.
There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.
The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.
Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.